7Baggers
 Biogen (BIIB) and Stoke Release Results from Dravet Syndrome Stu  GuruFocus Mon, 17 Nov 2025 13:33:15 GMT
 Biogen (BIIB) Reveals Key Findings from Dravet Syndrome Study  GuruFocus Mon, 17 Nov 2025 13:33:13 GMT
 (stok) as a liquidity pulse for institutional tactics  news.stocktradersdaily.com Mon, 10 Nov 2025 14:38:02 GMT
 research analysts offer predictions for stok fy2025 earnings  MarketBeat Sat, 08 Nov 2025 11:47:20 GMT
 cantor fitzgerald issues negative estimate for stok earnings  MarketBeat Sat, 08 Nov 2025 11:47:20 GMT
 what is leerink partnrs' forecast for stok fy2025 earnings?  MarketBeat Sat, 08 Nov 2025 11:47:19 GMT
 what is hc wainwright's estimate for stok fy2025 earnings?  MarketBeat Sat, 08 Nov 2025 11:47:19 GMT
 hc wainwright has bearish forecast for stok fy2029 earnings  MarketBeat Fri, 07 Nov 2025 14:29:19 GMT
 Stoke Therapeutics (NASDAQ:STOK) Given Buy Rating at BTIG Research  MarketBeat Thu, 06 Nov 2025 08:00:00 GMT
 Stoke Therapeutics (STOK) Price Target Raised to $28 by Canaccor  GuruFocus Wed, 05 Nov 2025 19:18:40 GMT
 stoke therapeutics earnings missed by $0.07, revenue topped estimates  Investing.com Australia Wed, 05 Nov 2025 19:04:21 GMT
 BTIG Reiterates Stoke Therapeutics (STOK) Buy Recommendation  Nasdaq Wed, 05 Nov 2025 12:03:00 GMT
 6 Analysts Have This To Say About Stoke Therapeutics  Benzinga Wed, 05 Nov 2025 11:45:33 GMT
 btig reiterates buy rating for stoke therapeutics (stok) with $3  GuruFocus Wed, 05 Nov 2025 10:38:24 GMT
 stoke therapeutics q3 2025 earnings call transcript  MarketBeat Wed, 05 Nov 2025 09:29:16 GMT
 td cowen maintains stoke therapeutics(stok.us) with buy rating  富途牛牛 Wed, 05 Nov 2025 05:47:54 GMT
 Decoding Stoke Therapeutics Inc (STOK): A Strategic SWOT Insight  GuruFocus Wed, 05 Nov 2025 05:38:00 GMT
 stoke therapeutics inc (stok) q3 2025 earnings call highlights:  GuruFocus Wed, 05 Nov 2025 05:17:52 GMT
 stoke therapeutics' revenue beats expectations but losses widen  Finimize Tue, 04 Nov 2025 22:55:46 GMT
 stoke therapeutics inc (stok) q3 2025 earnings: revenue surges t  GuruFocus Tue, 04 Nov 2025 21:45:42 GMT
 stoke therapeutics, inc. (stok) q3 fy2025 earnings call transcript  Yahoo Finance Tue, 04 Nov 2025 21:30:00 GMT
 stoke therapeutics reports q3 eps (65c), consensus (57c)  TipRanks Tue, 04 Nov 2025 21:28:09 GMT
 stoke therapeutics : q3 2025 webcast slides  MarketScreener Tue, 04 Nov 2025 21:22:51 GMT
 stoke therapeutics hits day low of $24.50 amid price pressure  Markets Mojo Tue, 04 Nov 2025 21:04:45 GMT
 Stoke Therapeutics earnings missed by $0.07, revenue topped estimates  Investing.com Tue, 04 Nov 2025 08:00:00 GMT
 stoke therapeutics (stok): jp morgan raises price target, mainta  GuruFocus Mon, 03 Nov 2025 16:35:52 GMT

Stoke Therapeutics, Inc
(NASDAQ:STOK) 

STOK stock logo

Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary ribonucleic acid therapeutics platform, Targeted Augmentat...

Founded: 2015
IPO Price: $18 (Jun 19, 2019)
Full Time Employees: 56
CEO: Edward M. Kaye  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends